Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Consensus recommendations for the diagnosis and treatment of primary progressive multiple sclerosis in Latin America.
Cristiano E, Rojas JI, Abad P, Adoni T, Barahona J, Becker J, Carrá A, Flores J, Fruns M, Fernández Liguori N, Garcea O, García Bónito J, Giunta D, Gracia F, Hamuy F, Macias Islas MA, Navas C, Boschetti LO, Patrucco L, Sato DK, Correale J. Cristiano E, et al. J Neurol Sci. 2018 Oct 15;393:4-13. doi: 10.1016/j.jns.2018.07.024. Epub 2018 Jul 31. J Neurol Sci. 2018. PMID: 30096568
Biological and nonbiological complex drugs for multiple sclerosis in Latin America: regulations and risk management.
Carrá A, Macías Islas MA, Tarulla A, Bichuetti DB, Finkelsztejn A, Fragoso YD, Árcega-Revilla R, Cárcamo Rodríguez C, Durán JC, Bonitto JG, León R, Oehninger Gatti C, Orozco G, Vizcarra Escobar D. Carrá A, et al. Expert Rev Neurother. 2015 Jun;15(6):597-600. doi: 10.1586/14737175.2015.1042456. Epub 2015 Apr 30. Expert Rev Neurother. 2015. PMID: 25924772
The effects of long-term exposure to disease-modifying drugs during pregnancy in multiple sclerosis.
Fragoso YD, Boggild M, Macias-Islas MA, Carra A, Schaerer KD, Aguayo A, de Almeida SM, Alvarenga MP, Alvarenga RM, Alves-Leon SV, Arruda WO, Brooks JB, Comini-Frota ER, Ferreira ML, Finkelsztejn A, Finkelsztejn JM, de Freitas LD, Gallina AS, da Gama PD, Georgetto S, Giacomo MC, Gomes S, Gonçalves MV, Grzesiuk AK, Kaimen-Maciel DR, Lopes J, Lourenco GA, Malfetano FR, Morales NM, Morales Rde R, Oliveira CL, Onaha P, Patroclo C, Ribeiro SB, Ribeiro TA, Salminen HJ, Santoro P, Seefeld M, Soares PV, Tarulla A, Vasconcelos CC. Fragoso YD, et al. Clin Neurol Neurosurg. 2013 Feb;115(2):154-9. doi: 10.1016/j.clineuro.2012.04.024. Epub 2012 May 26. Clin Neurol Neurosurg. 2013. PMID: 22633835
A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial.
Ziemssen T, Bajenaru OA, Carrá A, de Klippel N, de Sá JC, Edland A, Frederiksen JL, Heinzlef O, Karageorgiou KE, Lander Delgado RH, Landtblom AM, Macías Islas MA, Tubridy N, Gilgun-Sherki Y. Ziemssen T, et al. J Neurol. 2014 Nov;261(11):2101-11. doi: 10.1007/s00415-014-7446-0. Epub 2014 Aug 14. J Neurol. 2014. PMID: 25119836 Free PMC article.
Erratum to: A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial.
Ziemssen T, Bajenaru OA, Carrá A, de Klippel N, Correia de Sá J, Edland A, Frederiksen JL, Heinzlef O, Karageorgiou KE, Lander Delgado RH, Landtblom AM, Macías Islas MA, Tubridy N, Gilgun-Sherki Y. Ziemssen T, et al. J Neurol. 2015 Jan;262(1):248. doi: 10.1007/s00415-014-7565-7. J Neurol. 2015. PMID: 25417969 Free PMC article. No abstract available.
57 results